Consensus Ventas, Inc.

Stocks

VTR

US92276F1003

Specialized REITs

Market Closed - NYSE 07:00:02 27/10/26 am AEDT			5-day change	1st Jan Change
87.42 ^USD	+0.71%		+3.44%	+12.97%

20/10	Ventas, Inc. acquired HarborChase of Palm Beach Gardens from Silverstone Healthcare Company, LLC for $28.6 million.	CI
13/10	Barclays Adjusts Price Target on Ventas to $91 From $102	MT

Evolution of the Average Target: Ventas, Inc.

Evolution of the Target Price: Ventas, Inc.

Changes in Analyst Recommendations: Ventas, Inc.

2991e8f5440a49f8ee7c616d3.ONg9e9arm7dXnLRPlybVpmKsq_DJgGcVgEhlCCCNZ9c.d7FULoDlwYZu-MUQ-G62yAuZ7pmMsDFPzzE2aWzlJqNUqGdOk8fR1iDPgA~37fc72f163b345dd2058c240b8acb2f2

Analysts' recommendations: Ventas, Inc.

13/10	Barclays Adjusts Price Target on Ventas to $91 From $102	MT
12/10	Jefferies Adjusts Price Target on Ventas to $95 From $102	MT
21/09	Evercore ISI Adjusts Price Target on Ventas to $100 From $101, Maintains Outperform Rating	MT
02/09	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT
02/09	JPMorgan Adjusts Price Target on Ventas to $104 From $94, Maintains Overweight Rating	MT
01/09	Wells Fargo Adjusts Price Target on Ventas to $104 From $96, Maintains Overweight Rating	MT
31/08	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT
15/08	Ventas Earnings Growth Supported by Strong Senior Housing Trends, RBC Says	MT
14/08	RBC Adjusts Price Target on Ventas to $99 From $98, Maintains Outperform Rating	MT
12/08	Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating	MT
11/08	BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating	MT
06/08	Argus Research Adjusts Ventas Price Target to $98 From $92	MT
04/08	Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
04/08	Evercore ISI Adjusts Price Target on Ventas to $101 From $96, Maintains Outperform Rating	MT
03/08	BMO Capital Adjusts Price Target on Ventas to $105 From $100, Maintains Outperform Rating	MT
31/07	BNP Paribas Adjusts Ventas Price Target to $110 From $93, Maintains Outperform Rating	MT
24/07	Goldman Sachs Adjusts Price Target on Ventas to $114 From $110, Maintains Buy Rating	MT
22/07	Mizuho Adjusts Price Target on Ventas to $104 From $98, Maintains Outperform Rating	MT
16/07	Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating	MT
11/07	Scotiabank Adjusts Price Target on Ventas to $93 From $88	MT
01/07	Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating	MT
18/06	Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating	MT
16/06	Deutsche Bank Lifts Price Target on Ventas to $100 From $95, Keeps Buy Rating	MT
01/06	Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating	MT
26/05	BofA Adjusts Price Target on Ventas to $110 From $102	MT

More recommendations

Healthcare REITs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	VENTAS, INC.					+15.78%
	WELLTOWER INC.					+9.79%
	EQUINIX, INC.					+28.99%
	AMERICAN TOWER CORPORATION					+14.17%
	DIGITAL REALTY TRUST, INC.					+29.36%
	PUBLIC STORAGE					+6.17%
	CROWN CASTLE INC.					+8.75%
	IRON MOUNTAIN INCORPORATED					+30.96%
	EXTRA SPACE STORAGE INC.					+9.13%
	VICI PROPERTIES, INC.					+31%
	Average					+18.41%
	Weighted average by Cap.					+17.06%